COPD

By Leontina Postelnicu 12:58 pm May 23, 2019
Innovation and tech company Satellite Applications Catapult and the NHS Arden and Greater East Midlands Commissioning Support Unit (CSU) announced this week that they have agreed a formal partnership that looks at leveraging the potential of satellite technology in the digital transformation of healthcare. Oxfordshire-based Satellite Applications Catapult, which was established by Innovate UK in...
By Dave Muoio 02:31 pm April 2, 2019
The Loop System, a continuous remote monitor developed by Palo Alto-based startup Spry Health, received 510(k) clearance from the FDA last Friday, according to an update to the agency’s database that was confirmed by the company. Designed for management of COPD and other chronic conditions, the wristband wearable collects and monitors a user’s pulse-oximetry, respiration, heart rate and blood...
By Jonah Comstock 02:41 pm March 29, 2019
At MEDinIsrael 2019 this week, a conference in Tel Aviv sponsored by the Israeli Export Institute, Dr. Lena Granovsky, director of analytics and big data at Teva Pharmaceuticals, spoke on and off stage about the work the top Israeli pharma company has been doing in digital health. These topics included the company's recently FDA-cleared smart inhaler ProAir Digihaler, as well as more broad...
By Dean Koh 12:00 am February 7, 2019
Digital therapeutics company Kaia Health has unveiled a feasibility study to examine the impact of its digital therapeutic treatment of Chronic Obstructive Pulmonary Disease (COPD) on Japan’s ageing population. This follows a German pilot study which successfully decreased symptoms. COPD is an umbrella term to describe chronic lung diseases that cause limitations in lung airflow. According to the...
By Dave Muoio 12:46 pm January 23, 2019
While recent news of international product launches and recent M&As might suggest a cutthroat market, new data released this week by Research2Guidance suggest that there is still plenty of room in the digital respiratory health sector for both existing and new market players. According to “The Global Digital Respiratory Solutions Market 2009-2023” report, roughly 210 million asthma and COPD...
By Jonah Comstock 03:32 pm January 10, 2019
Respiratory health company Propeller Health, which was recently acquired by ResMed for $225 million, announced this week in San Francisco a partnership with Walgreens and a new feature for users of its platform. The new feature, called My Pharmacy, will allow Propeller’s end users, patients with asthma and COPD, to connect to pharmacy services without leaving the Propeller app. At launch, users...
By Dave Muoio 03:47 pm December 31, 2018
Jerusalem-based Teva Pharmaceuticals’ sensor-packed, app-connected digital inhaler has recently received marketing approval from the US FDA, according to a release from the company. The device will first become available next year through a “small number” of healthcare system pilot partnerships, with a full national launch currently planned for 2020. Teva’s ProAir Digihaler is indicated for the...
By Dave Muoio 04:03 pm May 30, 2018
Today, Madison, Wisconsin-based digital respiratory health company Propeller Health announced a $20 million funding round led by a $10 million investment from Aptar Pharma. Existing investors Safeguard Scientifics, Social Capital, Hikma Ventures, 3M Ventures, and SR One comprised the other half of the round. According to a release, the new funding will be invested into the company’s digital...
By Dave Muoio 11:24 am April 2, 2018
Smart inhaler company Adherium announced last week that it has received 510(k) clearance for over-the-counter sales of its inhaler monitoring device for AstraZeneca’s Symbicort aerosol inhaler, called the SmartTouch for Symbicort. Adherium — which is headquartered in San Mateo, California, but holds currently offices in Melbourne, Australia; Auckland, New Zealand; and Amstelveen, The Netherlands...
By Laura Lovett 12:10 pm February 19, 2018
A socially assistive robot could be key to helping people with COPD manage their condition at home. A recent study published in JMIR, found that COPD patients that had a take-home a robot following a hospitalization were more likely to adhere to their medications and complete their rehabilitation excercises than their peers that did not have a robot.  In fact, the intervention group had a 48.5...